Semaphorin 3s signaling in the central nervous system: Mechanisms and therapeutic implication for brain diseases

IF 12.5 1区 医学 Q1 PHARMACOLOGY & PHARMACY
Ya-Ping Lu , Yi-Ling Luo , Zhou-Yue Wu , Chao Han , Yin-Zhi Jin , Jun-Ming Han , Shu-Yang Chen , Fei Teng , Feng Han , Xiu-Xiu Liu , Ying-Mei Lu
{"title":"Semaphorin 3s signaling in the central nervous system: Mechanisms and therapeutic implication for brain diseases","authors":"Ya-Ping Lu ,&nbsp;Yi-Ling Luo ,&nbsp;Zhou-Yue Wu ,&nbsp;Chao Han ,&nbsp;Yin-Zhi Jin ,&nbsp;Jun-Ming Han ,&nbsp;Shu-Yang Chen ,&nbsp;Fei Teng ,&nbsp;Feng Han ,&nbsp;Xiu-Xiu Liu ,&nbsp;Ying-Mei Lu","doi":"10.1016/j.pharmthera.2025.108800","DOIUrl":null,"url":null,"abstract":"<div><div>Class 3 semaphorins (Sema3s), identified as secreted soluble proteins, present many therapeutic potentials. Recent evidence has suggested that Sema3s as molecular cue participate in neuroregulation, angiogenesis, and microenvironment homeostasis of the central nervous system. Moreover, Sema3s signaling pathways may be targeted for enhancing neural network connectivity, promoting neural regeneration and repair, and inhibiting pathological angiogenesis. Due to the complex co-expression patterns and crosstalk among Sema3s, new drugs targeting Sema3s-related signaling pathways are expected to be discovered to counter brain diseases. This review summarizes the specific roles of Sema3s in pathological processes of various brain diseases, and provides potential targeted strategies for the prevention and treatment.</div></div>","PeriodicalId":402,"journal":{"name":"Pharmacology & Therapeutics","volume":"267 ","pages":"Article 108800"},"PeriodicalIF":12.5000,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163725825000129","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Class 3 semaphorins (Sema3s), identified as secreted soluble proteins, present many therapeutic potentials. Recent evidence has suggested that Sema3s as molecular cue participate in neuroregulation, angiogenesis, and microenvironment homeostasis of the central nervous system. Moreover, Sema3s signaling pathways may be targeted for enhancing neural network connectivity, promoting neural regeneration and repair, and inhibiting pathological angiogenesis. Due to the complex co-expression patterns and crosstalk among Sema3s, new drugs targeting Sema3s-related signaling pathways are expected to be discovered to counter brain diseases. This review summarizes the specific roles of Sema3s in pathological processes of various brain diseases, and provides potential targeted strategies for the prevention and treatment.
中枢神经系统信号素3s信号:脑疾病的机制和治疗意义。
3类信号蛋白(Sema3s)是一种可分泌的可溶性蛋白,具有多种治疗潜力。最近的研究表明,Sema3s作为分子线索参与中枢神经系统的神经调节、血管生成和微环境稳态。此外,Sema3s信号通路可能具有增强神经网络连通性、促进神经再生和修复、抑制病理性血管生成的作用。由于Sema3s之间复杂的共表达模式和串扰,有望发现针对Sema3s相关信号通路的新药来对抗脑部疾病。本文综述了Sema3s在各种脑部疾病病理过程中的具体作用,并为其预防和治疗提供了潜在的针对性策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
23.00
自引率
0.70%
发文量
222
审稿时长
90 days
期刊介绍: Pharmacology & Therapeutics, in its 20th year, delivers lucid, critical, and authoritative reviews on current pharmacological topics.Articles, commissioned by the editor, follow specific author instructions.This journal maintains its scientific excellence and ranks among the top 10 most cited journals in pharmacology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信